Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial

PITCH Consortium, Matthew W. Jenner, Roger G Owen, Dickens Pratt, Gordon Cook, Alex Richter, Mark Drayson, Martin F Kaiser

Research output: Contribution to journal › Article › peer-review

44 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial'. Together they form a unique fingerprint.

Medicine & Life Sciences